Jonathan B Whitchurch

Dr. Jonathan B Whitchurch


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2021 in Cell
Verified
Journal Article
Open access
MGMiao Gui
Miao Gui
HFHannah Farley
Hannah Farley
PAPriyanka Anujan
Priyanka Anujan
JAJacob R. Anderson
Jacob R. Anderson
DMDale W. Maxwell
Dale W. Maxwell
ABAlan Brown
Alan Brown
Dynein-decorated doublet microtubules (DMTs) are critical components of the oscillatory molecular machine of cilia, the axoneme, and have luminal surfaces patterned periodically by microtubule inner proteins (MIPs). Here we present an atomic model of the 48-nm repeat of a mammalian DMT, derived from a cryoelectron microscopy (cryo-EM) map of the complex isolated from bovine respiratory cilia. The structure uncovers principles of doublet microtubule organization and features specific to vertebrate cilia, including previously unknown MIPs, a luminal bundle of tektin filaments, and a pentameric dynein-docking complex. We identify a mechanism for bridging 48- to 24-nm periodicity across the microtubule wall and show that loss of the proteins involved causes defective ciliary motility and laterality abnormalities in zebrafish and mice. Our structure identifies candidate genes for diagnosis of ciliopathies and provides a framework to understand their functions in driving ciliary motility.

5 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
ENEmeli M. Nilsson
Emeli M. Nilsson
KLKristian B. Laursen
Kristian B. Laursen
JWJonathan B Whitchurch
Jonathan B Whitchurch
AMAndrew McWilliam
Andrew McWilliam
NØNiels Ødum
Niels Ødum
NMNigel P Mongan
Nigel P Mongan
MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators

1 October 2018 in EBioMedicine
Verified
Journal Article
Open access
NLNgee Lek
Ngee Lek
RTRieko Tadokoro-Cuccaro
Rieko Tadokoro-Cuccaro
JWJonathan B Whitchurch
Jonathan B Whitchurch
BMBismoy Mazumder
Bismoy Mazumder
HMHarriet Miles
Harriet Miles
IHIeuanarwel Hughes
Ieuanarwel Hughes
PAIS exhibits a complex spectrum of phenotypes and pubertal outcomes. The paucity of reliable prognostic indicators can confound management decisions including sex-of-rearing. We assessed whether external masculinisation score (EMS) at birth or functional assays correlates with pubertal outcome in PAIS patients and whether the EMS is helpful in sex assignment. We collected pubertal outcome data for 27 male-assigned PAIS patients, all with confirmed androgen receptor (AR) mutations, including two previously uncharacterized variants (I899F; Y916C). Patients were grouped as follows; EMS at birth <5 and ≥ 5 (EMS in normal males is 12; median EMS in PAIS is 4·7) and pubertal outcomes compared. Only 6/9 patients (67%) with EMS <5 underwent spontaneous onset of puberty, versus all 18 patients with EMS ≥5 (p = .03). Only 1/6 patients (17%) with EMS <5 developed adult genitalia reaching Tanner stage 4 or 5, versus 11/13 (85%) with EMS ≥5 (p = 0·01). There was no significant difference between the two groups of patients in being prescribed androgen replacement, who reached adult testicular volume ≥ 15 ml, pubic hair Tanner stage 4 or 5, above average adult height, had gynaecomastia, and mastectomy. No correlation was observed between EMS and in vitro AR function. In PAIS with AR mutation, birth EMS is a simple predictor of spontaneous pubertal onset and satisfactory adult genitalia. This provides useful information when discussing the likely options for management at puberty. FUND: European Commission Framework 7 Programme, NIHR Cambridge Biomedical Research Centre, BBSRC DTP.

16 March 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JFJoel Fulton
Joel Fulton
BMBismoy Mazumder
Bismoy Mazumder
JWJonathan B Whitchurch
Jonathan B Whitchurch
CMCintia J Monteiro
Cintia J Monteiro
HCHilary M Collins
Hilary M Collins
DHDavid M. Heery
David M. Heery
Photoreceptor-specific nuclear receptor (PNR/NR2E3) and Tailless homolog (TLX/NR2E1) are human orthologs of the NR2E group, a subgroup of phylogenetically related members of the nuclear receptor (NR) superfamily of transcription factors. We assessed the ability of these NRs to form heterodimers with other members of the human NRs representing all major subgroups. The TLX ligand-binding domain (LBD) did not appear to form homodimers or interact directly with any other NR tested. The PNR LBD was able to form homodimers, but also exhibited robust interactions with the LBDs of peroxisome proliferator-activated receptor-γ (PPARγ)/NR1C3 and thyroid hormone receptor b (TRb) TRβ/NR1A2. The binding of PNR to PPARγ was specific for this paralog, as no interaction was observed with the LBDs of PPARα/NR1C1 or PPARδ/NR1C2. In support of these findings, PPARγ and PNR were found to be co-expressed in human retinal tissue extracts and could be co-immunoprecipitated as a native complex. Selected sequence variants in the PNR LBD associated with human retinopathies, or a mutation in the dimerization region of PPARγ LBD associated with familial partial lipodystrophy type 3, were found to disrupt PNR/PPARγ complex formation. Wild-type PNR, but not a PNR309G mutant, was able to repress PPARγ-mediated transcription in reporter assays. In summary, our results reveal novel heterodimer interactions in the NR superfamily, suggesting previously unknown functional interactions of PNR with PPARγ and TRβ that have potential importance in retinal development and disease.

1 August 2017 in Placenta
Verified
Journal Article
Closed access
VMVeronika M. Metzler
Veronika M. Metzler
SBSimone de Brot
Simone de Brot
RRRobert S. Robinson
Robert S. Robinson
JJJennie N. Jeyapalan
Jennie N. Jeyapalan
Emad A RakhaEmad A Rakha
Emad A Rakha
NMNigel P Mongan
Nigel P Mongan

12 January 2024 in Cells
Verified
Journal Article
Open access
PDF file
JWJonathan B Whitchurch
Jonathan B Whitchurch
SSSophia Schneider
Sophia Schneider
AHAlina Christine Hilger
Alina Christine Hilger
RKRicarda Köllges
Ricarda Köllges
JSJil D. Stegmann
Jil D. Stegmann
Heiko ReutterHeiko Reutter
Heiko Reutter
Besides visceral heterotaxia, Pkd1l1 null mouse embryos exhibit general edema and perinatal lethality. In humans, congenital chylothorax (CCT) is a frequent cause of fetal hydrops. In 2021, Correa and colleagues reported ultrarare compound heterozygous variants in PKD1L1 exhibiting in two consecutive fetuses with severe hydrops, implicating a direct role of PKD1L1 in fetal hydrops formation. Here, we performed an exome survey and identified ultrarare compound heterozygous variants in PKD1L1 in two of the five case–parent trios with CCT. In one family, the affected carried the ultrarare missense variants c.1543G>A(p.Gly515Arg) and c.3845T>A(p.Val1282Glu). In the other family, the affected carried the ultrarare loss-of-function variant (LoF) c.863delA(p.Asn288Thrfs*3) and the ultrarare missense variant c.6549G>T(p.Gln2183His). Investigation of the variants’ impact on PKD1L1 protein localization suggests the missense variants cause protein dysfunction and the LoF variant causes protein mislocalization. Further analysis of Pkd1l1 mutant mouse embryos revealed about 20% of Pkd1l1−/− embryos display general edema and pleural effusion at 14.5 dpc. Immunofluorescence staining at 14.5 dpc in Pkd1l1−/− embryos displayed both normal and massively altered lymphatic vessel morphologies. Together, our studies suggest the implication of PKD1L1 in congenital lymphatic anomalies, including CCTs.